Skip to main content

Table 4 Details of cases of loss of consciousness on the manufacturer’s reports of adverse events

From: Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report

Sex

Age

Relationship with Cet

Outcome

Period from the infusion

Diagnosis (metastatic site)

Concomitant drug

Under investigation

Female

60

Yes

Recovered

5 min

Colon cancer (peritoneum, lymph nodes)

Dexamethasone, Azasetron

 

Male

80

Yes

Recovered

1 day

Colon cancer (liver)

Chlorpheniramine, Dexamethasone, Granisetron

 

Male

70

Yes

Not recovered

Not mentioned

Colon cancer

Fluorouracil, calcium folinate, oxaliplatin

Yes

  1. Cet cetuximab, DEX dexamethasone sodium phosphate, Azasetron azasetron hydrochloride, Chlorpheniramine chlorpheniramine maleate, Granisetron granisetron hydrochloride